Specifically, our evaluation of 1490 DLBCL patient samples revealed significantly increased levels of BCLW mRNA in DLBCL, and for patients with lower levels of BCL2, increased BCLW levels correlated with reduced survival and was an independent negative prognostic indicator of survival [47,66]. Here, BCL2 is linked to diffuse large B-cell lymphoma.